VitalStone Financial’s AbbVie ABBV Stock Holding History

VitalStone Financial’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$46.6K	Buy	236 +2	+0.9%	+$373	0.03%	176
2024 Q2	$40.2K	Buy	234 +2	+0.9%	+$331	0.03%	182
2024 Q1	$42K	Hold	232	–	–	0.03%	182
2023 Q4	$36K	Hold	232	–	–	0.03%	180
2023 Q3	$32K	Sell	232 -10	-4%	-$1.47K	0.03%	160
2023 Q2	$39K	Buy	242 +166	+218%	+$24.3K	0.02%	395
2023 Q1	$10K	Sell	76 -156	-67%	-$23.9K	0.01%	208
2022 Q4	$37K	Buy	+232	New	+$35.6K	0.03%	196

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

VitalStone Financial's ABBV Position: Q3 2024 in Review

VitalStone Financial increased its AbbVie (ABBV) stake by 0.85% in Q3 2024, buying an estimated $373 and bringing the position to 236 shares worth $46.6K. The position accounts for 0.03% of the portfolio, ranked #176.

VitalStone Financial first reported a position in ABBV in Q4 2022 and has held it in 8 quarters since. 3,499 funds tracked by Wall St. Rank hold ABBV as of Q3 2024.

VitalStone Financial held 236 shares of AbbVie worth $46.6K as of Q3 2024.
VitalStone Financial bought 2 AbbVie shares in Q3 2024, an estimated $373.
AbbVie made up 0.03% of VitalStone Financial's portfolio in Q3 2024, its #176 holding.
VitalStone Financial first reported a position in AbbVie in Q4 2022 and has held it in 8 quarters since.
3,499 funds tracked by Wall St. Rank held AbbVie as of Q3 2024.

Based on VitalStone Financial's 13F filing for Q3 2024, filed 11 Oct 2024.